Development of Telmisartan Nanocrystal-Based Dissolving Microneedle for Brain Targeting via Trigeminal Pathway: A Potentially Promising Treatment for Alzheimer’s with an Improved Pharmacokinetic Profile

Post time 2024-5-1 16:47:02

journal：ACS Applied Bio Materials

Authors：Aqilah F. Madani; Muhammad A. Syauqi; Jihan A. Permatasari; Annisa A. Putri; Fadel M; Andi Dian Permana

Published date：2024-4-15

DOI：10.1021/acsabm.4c00246

PDF link：https://pubs.acs.org/doi/pdf/10.1021/acsabm.4c00246

Article link：http://dx.doi.org/10.1021/acsabm.4c00246

Article Source：American Chemical Society (ACS)。

Remark：

Post time 2024-5-1 16:47:03

: This post has been completed
Completed attachments will be deleted within 24 hours.

[ACS] Development of Telmisartan Nanocrystal-Based Dissolving Microneedle for Brain Targeting via Trigeminal Pathway: A Potentially Promising Treatment for Alzheimer’s with an Improved Pharmacokinetic Profile

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[ACS] Development of Telmisartan Nanocrystal-Based Dissolving Microneedle for Brain Targeting via Trigeminal Pathway: A Potentially Promising Treatment for Alzheimer’s with an Improved Pharmacokinetic Profile Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[ACS] Development of Telmisartan Nanocrystal-Based Dissolving Microneedle for Brain Targeting via Trigeminal Pathway: A Potentially Promising Treatment for Alzheimer’s with an Improved Pharmacokinetic Profile